McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 853.37
+4.43 (0.52%)
At close: Nov 7, 2025
McKesson Market Cap
McKesson has a market cap or net worth of 79.87 billion as of November 7, 2025. Its market cap has increased by 58.86% in one year.
Market Cap
79.87B
Enterprise Value
85.27B
Revenue
287.97B
Ranking
n/a
PE Ratio
26.62
Stock Price
853.37
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 79.87B, an increase of 8,730.80%. That is a compound annual growth rate of 15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 79.87B | 38.22% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | 20.45B | 8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 66.53B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |